Cayman Chemical SM-102 amino lipid

Tuesday, 05 September, 2023 | Supplied by: Sapphire Bioscience

SM-102 is an ionisable cationic amino lipid that has been used in combination with other lipids in the formation of lipid nanoparticles (LNPs). Administration of luciferase mRNA in SM-102-containing LNPs induces hepatic luciferase expression in mice. Formulations containing SM-102 have been used in the development of LNPs for delivery of mRNA-based vaccines.

Cayman Chemical’s SM-102 is distributed in Australia and New Zealand by Sapphire Bioscience.

Online: www.sapphirebioscience.com
Phone: 02 9698 2022

Cayman Chemical Stem Cell Small Molecule Screening Library

The screening library contains more than 140 small molecules that are known either to induce...

Cayman Chemical Bio-Active Lipid I Screening Library (96-Well)

Cayman Chemical's Bio-Active Lipid I Screening Library consists of 13 plates and contains...

Echelon Biosciences ionisable lipids

Echelon Biosciences' ionisable lipids are the key components of lipid nanoparticles (LNPs)...

Content from other channels on our network

Clear Signals Start with MedGel® ECG Electrodes

MDMA-AP for PTSD clinical practice guideline — consultation open

Survey opens to all of Australia's doctors in training

'Worried they're getting worse' rolls out across all NSW public hospitals

Adelaide's $90 million Eastwood Private Hospital now open

Manufacturer marks 15 years of aseptic PET packaging

Fresh produce executive program debuts in NZ

Productivity on the agenda for food and grocery manufacturing

Six on the shelf: from high-protein milk to bubbles in space

New Report Reveals Next-Gen Tech Driving Major Growth in Australian Food Processing

Robotics and automation: transforming the food and beverage industry

Engineers Australia calls for gold-standard engineer registration

Data-driven insights: how AI is transforming industrial processes

IMARC 2025 turns up the innovation spotlight

Designing smarter electrical equipment embedded with AI